Abbreviations & Acronyms AUS = artificial urinary sphincter BMI = body mass index CAD = coronary artery disease HTN = hypertension IQR = interquartile range SUI = stress urinary incontinence XRT = external beam radiation Objective: Artificial urinary sphincter malfunctions can occur in any of the individual components. Preoperative identification of the malfunctioning component can be valuable for patient counseling and surgical planning. The optimal strategy for repair of failed artificial urinary sphincter components is debated given the relative rarity of the situation. The aim of the present study was to evaluate the relationship of time to failure with failed artificial urinary sphincter component and to compare our outcomes of specific component versus complete device replacement. Methods: From 1983 to 2011, 1805 artificial urinary sphincter procedures were carried out at Mayo Clinic (Rochester, Minnesota, USA), of which 1072 patients underwent primary artificial urinary sphincter placement. Clinical variables, including time to failure, were evaluated for association with component failure. Bootstrap analysis was used to estimate the differences in time to reach a fixed percentage of component failure. Results: A total of 115 patients experienced device failure at a median follow up of 4.2 years. Urethral cuff, abdominal reservoir, scrotal pump and tubing malfunction occurred in 53 (4.9%), 26 (2.4%), 11 (1%) and 25 (2.3%) patients, respectively. Increasing age at the time of primary surgery was protective of cuff malfunction (hazard ratio 0.97, P = 0.04). Time to 3% urethral cuff failure outpaced other component failures (P < 0.05). Secondary failure-free rates after whole device versus specific component revisions were comparable (P = 0.38). Conclusions: Clinical predictors for artificial urinary sphincter failure continue to be difficult to establish. Although single component versus entire device replacement have similar outcomes, if pursuing single component revision, we recommend cuff-first interrogation in devices in place for >3 years, as this represents the most likely component to fail.
Introduction
SUI after prostatectomy is reported to occur in up to 50% of treated patients. [1] [2] [3] Although AUS placement is the gold standard in surgical management of moderate-to-severe male SUI, in a pooled analysis the overall reintervention rate is 26% (range 14.8-44.8%). [4] [5] [6] Specifically, device malfunction, with loss of fluid from the system, has been reported in 6.2% of cases (range 2-13.8%). 5 In these patients, the optimal management strategy is still debated. [7] [8] [9] [10] [11] [12] That is, there is significant variation in recommendations regarding under what conditions providers should consider replacing a single component versus exchanging the entire device. [7] [8] [9] [10] [11] 13 In our own practice, we have shown comparable outcomes of single component versus entire device replacement. 7 In cases where single component revision is being pursued, limited data exist to guide the surgical approach. That is, starting with the abdominal components versus a perineal approach with interrogation of the urethral cuff. 7, 14 For instance, several prior series showed that the urethral cuff is the most common component to fail overall, but predictors of which component is most likely to fail in specific scenarios remain unknown. 7, 15, 16 As such, a better understanding of clinical patterns of device component malfunction is an important consideration, as it might guide surgical practice.
As such, we sought to evaluate for clinical predictors, including time to primary device failure, that can predict the failed AUS component.
Methods
After institutional review board approval, we evaluated 1805 AUS procedures carried out at Mayo Clinic (Rochester, MN, USA) from 1983 to 2011. From this cohort, we identified 1072 patients that underwent primary AUS placement. Of these patients, 115 experienced mechanical device malfunction and underwent a subsequent revision at our institution. Patients were excluded from the study if they underwent AUS placement secondary to neurogenic bladder, were aged <18 years or declined research consent.
With regard to our approach to mechanical failures, all of our device implantations had 22 cc of iso-osmotic contrast placed in the abdominal reservoir and all the implanted devices were AMS 800 (Boston Scientific, Marlborough, MA, USA). 7 During evaluation for recurrent SUI after primary AUS implantation, we carried out a history and physical, cystoscopy, urine flow study with postvoid residual by ultrasound, and an abdominal X-ray (given contrast in the reservoir). Mechanical malfunction was confirmed by identifying loss of fluid from the AUS system on abdominal X-ray. Our approach towards revision surgery has historically taken into account the time from initial AUS placement, patient comorbidities and intraoperative findings to guide replacement of a single component versus the entire device. The surgical steps for our approach to revision surgery for mechanical failure were recently reported. 7 Briefly, when carrying out single component revision, we perform a repeat perineal dissection and initially test the device starting at the urethral cuff. If a leak in the cuff is identified, this component is removed and replaced, and the remainder of the device is left in situ. If the urethral cuff is intact, the abdominal reservoir is interrogated. If a leak is identified, this component is removed and replaced, with the scrotal pump left in situ. If no leak in the reservoir is identified, the reservoir and scrotal pump are evaluated and exchanged. Of note, any component that is interrogated is replaced with a new component, and therefore single component revision might not be possible depending on intraoperative findings.
Patient comorbidities and surgical variables were obtained from individual chart review. Device outcomes including time to failure, failed component, revision strategy (single component versus entire device) and secondary device outcome were retrospectively recorded. Device status was determined based on the last Mayo Clinic follow up, as well as written or telephone correspondence in the Department of Urology. Similarly, time to secondary AUS failure or censor was determined from time of AUS revision for mechanical device failure (secondary surgery) to tertiary surgery or date of last follow up.
Continuous features were summarized with medians, IQRs and ranges. Categorical variables were reported by frequency and percentages. Associations with individual component failure were evaluated using Cox proportional hazards regression models.
Bootstrap technique was used to determine if a fixed percentage of component failure was different between pump, tubing, reservoir and cuff components. After obtaining 750 bootstrap samples from a cohort of 1072 patients, the time to reach a fixed percentage of component failure and the differences between each pair of components were calculated for each bootstrap sample. The results were ordered, and the 95% confidence limits were calculated from the corresponding 2.5 and 97.5 percentiles. This analysis was carried out for 1%, and 3% component failure. Secondary revision-free survival was estimated using the Kaplan-Meier method and compared by the log-rank test. Association of secondary failure rate comparing replacement of the individual component versus the entire device was carried out using Cox regression models. Statistical analyses were carried out using version 9.4 of the SAS software package (SAS Institute, Cary, NC, USA). All tests were two-sided, with P-values of <0.05 considered statistically significant.
Results
Between 1983 and 2011, 1805 AUS procedures were carried out at our institution, of which 1072 male patients underwent primary AUS placement. The median follow up was 4.2 years (IQR 0.8, 7.9). During this time, 115 patients (10.7%) required subsequent intervention secondary to mechanical device failure. Urethral cuff, abdominal reservoir, scrotal pump and tubing malfunction occurred in 53 (4.9%), 26 (2.4%), 11 (1%) and 25 (2.3%) patients, respectively. Patient comorbidities, stratified by device outcome and failed component, are shown in Table 1 . As shown, patients with pump and tubing failures were more common in the earlier years of the study, and were rare in more contemporary cases.
Individual clinical variables were tested for an association with the risk of mechanical failure for each component (Table 2 ). Increasing patient age at the time of primary surgery was associated with a significantly decreased risk of urethral cuff malfunction (HR 0.97, 95% CI 0.94-1.00; P = 0.04). A higher BMI was not associated with the risk of urethral cuff failure (P = 0.47). Likewise, no other clinical variables were associated with the risk of failure of any specific component (Table 2) .
Cumulative incidence of specific component failure is shown in Figure 1 . As shown, before 2 years, the abdominal reservoir was the most likely failed component, whereas after 3 years, the urethral cuff was more common. Using bootstrap analysis, there was no evidence proving a significant difference in time to 1% component failure between any pairwise comparisons of components (Table S1 ). However, time to 3% urethral cuff failure was significantly shorter than other components (Table 3) .
Comparing specific component revisions versus complete device replacement, secondary AUS failure-free rates after whole device, cuff only, reservoir only, pump only and tubing only replacement at 5 years were 67.4%, 46.2%, 17.1%, 50% and 37.5%, respectively (Fig. 2) . On univariate analysis, there was no significant difference identified in the risk of repeat AUS malfunction with replacement of any specific component compared with entire device revision ( Table 4) .
Discussion
While AUS implantation represents the gold standard for surgical management of severe post-prostatectomy SUI, mechanical device failure occurs in up 12% of patients. 5 Revision strategies differ in offering entire device replacement versus single component revision. We have previously shown that entire device replacement has similar outcomes compared with single component replacement, with no increased risk of infection or erosion. 7 Here, in an effort to better inform surgical decision-making, we further evaluate clinical and temporal trends in AUS mechanical device failure. There is a paucity of reports identifying clinic predictors for mechanical device failure. 15, 16 Wang et al. reported in 149 patients that BMI >30 was associated with device malfunction. 15 In that study, the author hypothesized that increasing obesity may correlate with risk for hospitalization and catheterization, leading to possible damage of the device. In contrast, we did not find a similar association, though the majority of our patients were not obese (BMI >30). Previously, we identified that age was protective of device failure, though this analysis was not stratified by specific component. 7 Expanding on this, in the present study, we found increasing age to be associated with a decreased risk of cuff malfunction, but not associated with other component failures. This might in part be secondary to younger patients who experience device malfunction being more likely to pursue device revision. While we would expect to see this effect on all malfunctions, given cuff malfunctions occur most frequently, we might be underpowered to identify this relationship in patients with tubing, reservoir or pump malfunctions. In addition, coronary artery disease, hypertension, diabetes and history of prior pelvic radiation were not associated with mechanical device failure. Mechanical device failure has been reported to occur at a median time of 2-5 years. 15, 17 As such, we sought to evaluate whether time to failure could be used to identify the failed component. Previous studies have found cuff failures to represent up to 50% of component malfunctions. 9, 13 Using bootstrap analysis, we found that the time to a cumulative incidence of 1% failure was similar between cuff, tubing, pump and reservoir components. However, as device age increases, specifically after the 3-year time-point, urethral cuff failures outpace other component failures. Thus, if a surgeon is pursuing single component revision, in devices over 3 years old, the urethral cuff is the most likely failed component and they might elect to start with a perineal dissection. Before this time frame, the abdominal reservoir is as likely to fail, and starting with an abdominal dissection might prevent the need for repeat urethral dissections with the attendant risks, and allow for early device activation.
During our study period, rates of mechanical failure were noted to improve over each decade. Specifically, the jump from the 1980s to the 1990s saw a dramatic decline in scrotal pump and tubing malfunctions. This likely can be explained by significant device improvements made in the 1980s, as well as being within the early practice period of our reconstructive urologists. 18 However, although we did see a drop in cuff failures with the most recent device model in 1987, this still represents an area of potential improvements in the future.
To our knowledge, this is the first report on temporal trends in component failure. When carrying out device revision for mechanical device failure, single component versus entire device replacement have similar outcomes. 7 The present findings concur with previous reports, and further demonstrate comparable success rates between specific component repair and entire device replacement. In our practice, we generally favor entire device replacement, as we have had anecdotal cases of secondary device failures as a result of components left in situ. 7 However, in patients where single component repair is attempted, cuff failure should be considered as the likely source in devices >3 years-of-age.
Several limitations to the present study deserve attention. It was a retrospective review of AUS device implantation carried out by three surgeons at a single, high-volume tertiary referral center over 28 years. As such, differences in operative technique and patient population might not be generalizable to all settings. Furthermore, given the tertiary practice at our institution, patient follow up and subsequent procedures might be carried out by local urologists. We attempt to limit this bias through patient correspondence, but this is an imperfect means of follow up. In addition, our data on device malfunction rely on a patient pursuing revision for recurrent stress incontinence, and therefore we cannot account for those with recurrent incontinence that are not managed surgically. Finally, although our AUS database represents the largest single institution series, mechanical device failure is a relatively rare event and therefore our ability to ascertain statistically significant findings might be limited. Nevertheless, we believe our analysis furthers our understanding of AUS mechanical device failure.
No clinical factors could be determined to help predict component failure. However, cuff failures, over time, outpace all other component failures. While single component versus entire device replacement have similar outcomes, if pursuing single component revision, we recommend cuff-first interrogation in devices in place for >3 years, as this represents the most likely component to fail. 
